Trupanion (NASDAQ:TRUP) PT Lowered to $80.00 at Piper Sandler

Trupanion (NASDAQ:TRUPGet Rating) had its target price dropped by stock analysts at Piper Sandler from $95.00 to $80.00 in a report issued on Friday, The Fly reports. Piper Sandler’s price objective indicates a potential upside of 23.99% from the stock’s current price.

A number of other equities research analysts have also recently issued reports on the stock. Bank of America dropped their price target on shares of Trupanion from $118.00 to $110.00 and set a “buy” rating on the stock in a research note on Wednesday, April 20th. Zacks Investment Research lowered Trupanion from a “buy” rating to a “hold” rating in a report on Wednesday, May 4th. StockNews.com initiated coverage on Trupanion in a report on Thursday, March 31st. They set a “sell” rating on the stock. Canaccord Genuity Group reduced their price objective on shares of Trupanion from $140.00 to $100.00 in a report on Friday, April 29th. Finally, TheStreet downgraded Trupanion from a “c-” rating to a “d+” rating in a research report on Wednesday, April 6th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $99.60.

NASDAQ TRUP opened at $64.52 on Friday. The company’s 50-day moving average price is $76.28 and its 200-day moving average price is $96.74. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.16. The stock has a market cap of $2.63 billion, a PE ratio of -81.67 and a beta of 2.15. Trupanion has a 12 month low of $54.68 and a 12 month high of $158.25.

Trupanion (NASDAQ:TRUPGet Rating) last released its quarterly earnings results on Thursday, April 28th. The financial services provider reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.05). The firm had revenue of $206.00 million for the quarter, compared to analysts’ expectations of $202.32 million. Trupanion had a negative net margin of 4.26% and a negative return on equity of 8.66%. The business’s quarterly revenue was up 33.2% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.31) earnings per share. As a group, sell-side analysts forecast that Trupanion will post -0.77 earnings per share for the current year.

In related news, President Margaret Tooth sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, May 13th. The stock was sold at an average price of $66.71, for a total value of $66,710.00. Following the completion of the transaction, the president now directly owns 34,880 shares of the company’s stock, valued at $2,326,844.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Darryl Rawlings sold 4,000 shares of the company’s stock in a transaction that occurred on Friday, March 11th. The shares were sold at an average price of $81.04, for a total value of $324,160.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 27,758 shares of company stock valued at $2,228,675. Corporate insiders own 6.77% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. FNY Investment Advisers LLC purchased a new stake in Trupanion in the fourth quarter valued at approximately $28,000. Rational Advisors LLC lifted its stake in Trupanion by 112.5% in the fourth quarter. Rational Advisors LLC now owns 238 shares of the financial services provider’s stock valued at $31,000 after buying an additional 126 shares during the last quarter. Lindbrook Capital LLC purchased a new stake in Trupanion in the fourth quarter valued at approximately $36,000. Prospera Financial Services Inc purchased a new stake in Trupanion in the first quarter valued at approximately $49,000. Finally, Tcwp LLC purchased a new stake in Trupanion in the first quarter valued at approximately $54,000. 83.62% of the stock is owned by hedge funds and other institutional investors.

About Trupanion (Get Rating)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Read More

The Fly logo

Want More Great Investing Ideas?

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.